Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PATH vs MRNA✓SelectedUSD · MRNAPATH vs MRNA performance historyLatest closeAs of-0.08%11/06
Stock and ETF performance explorer

PATH vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-5.3%
MRNA return
+15.3%
Excess return
-20.6%
Maximum drawdown
-5.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1w.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.1%+5.3%-5.3%N/A
7D-5.3%+14.6%-20.0%N/A
All-5.3%+15.3%-20.6%N/A

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Beta-adjusted return needs at least 20 comparable returns and benchmark movement within each trailing regression window.

Cumulative Out/Under-Performance

Relative wealth over 1w: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Cumulative alpha will appear once a trailing regression window supports a beta estimate.

Updating return analytics…

1w analysis · Full analysis span regression · Available span rolling